Global Information
회사소개 | 문의 | 비교리스트

로봇 지원 수술 시스템 시장 : 성장, 동향, COVID-19의 영향과 예측(2021-2026년)

Robotic Assisted Surgery Systems Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

리서치사 Mordor Intelligence Pvt Ltd
발행일 2022년 01월 상품코드 995774
페이지 정보 영문 배송안내 2-3일 (영업일 기준)
US $ 4,750 ₩ 6,364,000 PDF & Excel (Single User License)
US $ 5,250 ₩ 7,033,000 PDF & Excel (Team License: Up to 7 Users)
US $ 6,500 ₩ 8,708,000 PDF & Excel (Site License)
US $ 8,750 ₩ 11,723,000 PDF & Excel (Corporate License)

로봇 지원 수술 시스템 시장 : 성장, 동향, COVID-19의 영향과 예측(2021-2026년) Robotic Assisted Surgery Systems Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
발행일 : 2022년 01월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

로봇 지원 수술 시스템 시장 규모는 2020년에 60억 3,127만 달러를 기록했습니다.

이 시장은 예측 기간 중 13.6%의 CAGR로 확대하며, 2026년에는 129억 7,008만 달러에 달할 것으로 예측되고 있습니다.

전 세계에서 증가하고 있는 COVID-19의 증례에 의해 외과수술이 당초 연기 또는 지연되었으므로 로봇 지원 수술 시장에 심각한 영향을 미치고 있습니다. 또한 COVID-19 관련 대책에 의한 선택적 시술의 지연은 특히 2020년에 로봇 지원 수술 시스템 시장 등의 제품에 악영향을 미쳤습니다. COVID-19는 2020년 로봇 지원 수술 시스템 제품의 생산에도 영향을 미쳤습니다.

그러나 이 증례가 증가함에 따라 로봇 지원 수술 시스템에 대한 선호도도 높아지고 있습니다. 이것은 정확하고 떨림 없는 수술이 가능하며, 저침습법의 이점 등 이것에 관련된 몇개의 이점이 있기 때문입니다.

시장의 성장을 촉진하는 주요 요인은 만성질환의 부담 증가와 저침습법에 대한 선호도의 증가와 함께 기술의 진보와 새로운 시장 기업의 참여입니다. 심혈관질환은 전 세계에서 가장 만연한 것으로 알려진 주요 사인입니다. 세계보건기구의 2020년 최신 데이터에 따르면 허혈성 심질환은 세계 총사망자수의 약 16%를 차지하고 있습니다. 또한 2000년 이후 허혈성 심질환에서 사망자수의 최대 증가가 보이며, 2019년에는 200만 명 이상 증가하며 890만 명을 기록했습니다. 심혈관질환의 이환율 상승에 의해 심폐 수술, CABG(coronary artery bypass grafting)가 증가하며, 이것은 로봇 지원 수술 시스템의 수요를 증가시킬 전망입니다.

그러나 이 시스템의 연간 유지보수 비용은 일회용 비품의 비용과 함께 이 로봇 시스템에서 매우 고액이며, 특히 중소득국 및 저소득국에서는 많은 기관 및 의료 시스템이 이 디바이스를 적응할 수 있는 능력에 미치지 못하고 있습니다.

로봇 지원 수술 시스템 시장에 대해 조사했으며, 시장의 개요와 제품 유형별, 용도별, 최종사용자별, 지역별 동향 및 시장에 참여하는 기업의 개요 등을 정리하여 전해드립니다.


제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 시장 역학

  • 시장 개요
  • 시장 촉진요인
    • 기술 진보의 증가와 새로운 시장 기업의 참여
    • 만성질환의 증례 증가와 저침습수술에 대한 선호도
  • 시장 억제요인
    • 엄격한 규제 프로세스와 고비용 디바이스
  • Porter's Five Forces 분석

제5장 시장 세분화

  • 제품 유형별
    • 시스템
    • 소모품과 액세서리
    • 소프트웨어와 서비스
  • 용도별
    • 부인과 수술
    • 심장혈관
    • 신경외과
    • 정형외과
    • 복강경 검사
    • 비뇨기과
    • 기타
  • 최종사용자별
    • 병원
    • 외래 수술 센터
    • 기타
  • 지역별
    • 북미
    • 유럽
    • 아시아태평양
    • 기타 지역

제6장 경쟁 구도

  • 기업 개요
    • Intuitive Surgical Inc.
    • Stryker Corporation
    • Johnson & Johnson Inc.(Verb Surgical Inc. and Auris Health Inc.)
    • SRI International Inc.
    • Accuray Incorporated
    • Think Surgical Inc.
    • Renishaw PLC
    • Medtronic PLC
    • Smith & Nephew PLC
    • Brainlab
    • NuVasive Inc.
    • Avatera Medical GmbH
    • Globus Medical
    • Zimmer Biomet

제7장 시장 기회 및 향후 전망

KSA 21.03.23

The robotic assisted surgery systems market is estimated to be valued at USD 6,031.27 million in 2020, and it is expected to reach USD 12,970.08 in 2026, witnessing a CAGR of 13.6% during the forecast period.

Globally, the rising number of COVID-19 cases has a profound impact on the robotic assisted surgery market, as surgical procedures initially had to be postponed or delayed. Furthermore, the delay of elective procedures due to COVID-19-related measures adversely affected the robotic assisted surgery systems market, especially in 2020. COVID-19 also impacted the production of robotic assisted surgery systems and products in 2020.

However, as these cases are rising, the preference for robotic assisted surgical systems is also increasing due to the several advantages associated with them, such as facilitation of precise, tremor-free surgery and benefits of minimally invasive methods.

The major factors driving the growth of the market are the rising technological advancements and the entry of new market players, along with the surging burden of chronic disorders and the rising preference for minimally invasive methods. Cardiovascular diseases are the most prevalent across the world, and they are the leading causes of death. As per the 2020 updates of the World Health Organization, ischemic heart disease is responsible for nearly 16% of the world's total number of deaths. Furthermore, since 2000, the highest increase in the number of deaths has been for ischemic heart disease, as it rose by more than 2 million to 8.9 million deaths in 2019. The rising prevalence of cardiovascular diseases is also increasing the number of cardiopulmonary surgeries and coronary artery bypass grafting (CABG) surgeries being performed. Thus, such factors may increase the demand for robotic assisted surgery systems.

However, the annual maintenance costs of these systems, along with their disposable supply costs, are quite high, which puts them beyond the reach of many institutions and healthcare systems, especially in middle-income and low-income countries.

Key Market Trends

The Surgical Robot Segment is Expected to Hold the Largest Share in the Robotic Assisted Surgery Systems Market

The surgical robot segment is expected to hold the largest share in the robotic assisted surgery systems market during the forecast period.

With the emergence of COVID-19, surgeries had to be postponed, which impacted the market for surgical robot systems negatively. According to the study based on 12 weeks of peak disruption to hospital services, published in the British Journal of Surgery in May 2020, due to COVID-19, around 28.4 million elective surgeries had to be canceled or postponed in 2020, globally. More than 580,000 planned surgeries in India had to be canceled or delayed due to the COVID-19 pandemic, according to a study conducted by an international consortium in May 2020.

However, surgeries are being resumed now. Thus, the rising preference for surgical robots due to the minimum level of intervention required and the declining risk of cross-contamination may upsurge the demand for surgical robots.

Many hospitals and other institutions are actively adopting these surgical robots to enhance their surgical procedures in terms of patient outcomes. For instance, in 2020, Apollo Hospital Networks installed about 80 robotic-assisted surgery set-ups across India to perform general, oncology, urology, and bariatric surgeries. Furthermore, in November 2020, it introduced the ''Robotic Joint Replacement Program'', wherein healthcare professionals use next-generation robotic systems for smaller incisions and other activities in partial and total knee replacement procedures.

North America is Expected to Hold a Significant Share in the Market in the Forecast Period

During this pandemic situation, the United States was one of the most affected countries, worldwide, which further significantly impacted the robotic assisted surgery systems market. The adoption of robotic assisted surgery systems may have declined during this period, as countries aimed at conserving and managing resources for curbing the spread of the disease.

North America is expected to dominate the overall robotic assisted surgery systems market throughout the forecast period. The major factors attributing to the growth are the rise in the burden of chronic diseases and technological advancements in robotic-assisted surgery systems. According to the Canadian Institute for Health Information's 2020 report, more than 62,000 hip replacements and over 75,000 knee replacements were performed in Canada during 2018-2019. This represents an increase of 20.1% and 22.5%, respectively, over the last five years. Additionally, joint replacements have increased, with more than 137,000 surgeries being performed annually and an estimated amount of USD 1.4 billion for inpatient hospital and physician costs (excluding rehabilitation). Hence, the rising number of surgical procedures may further support market growth. Furthermore, in September 2019, Medtronic PLC introduced Hugo RAS System, a robot-assisted surgery platform that is more flexible and cost-effective than other systems. Thus, with the above data points, it can be incurred that the market for robotic assisted surgery systems in this region may thrive during the forecast period.

Competitive Landscape

The robotic assisted surgery systems market is inclusive of international companies and local players. New market players with more funds for research and development are now entering the market. Moreover, big players in medical devices are also focusing on paving their way in the robotic assisted surgical systems market through mergers, acquisitions, etc. For instance, in December 2019, Ethicon, a division of Johnson & Johnson, announced to acquire stakes (of Verily) in Verb Surgical Inc. to strengthen Ethicon's capabilities in terms of surgery and advanced instrumentation. The deal was closed in February 2020. This move also helped the market grow. Some of the companies that are currently dominating the market are Intuitive Surgical Inc., Stryker Corporation, Johnson & Johnson Inc. (Verb Surgical Inc. and Auris Health Inc.), SRI International Inc., Accuray Incorporated, Think Surgical Inc., Renishaw PLC, Medtronic PLC, Smith & Nephew PLC, Brainlab, and NuVasive Inc.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support



  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study




  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Technological Advancements and Entry of New Market Players
    • 4.2.2 Increasing Cases of Chronic Diseases and Rising Preference to Minimally Invasive Surgeries
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Processes and High Cost of Devices
  • 4.4 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Buyers/Consumers
    • 4.4.2 Bargaining Power of Suppliers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Intensity of Competitive Rivalry


  • 5.1 By Product Type
    • 5.1.1 System
      • Surgical Robot
      • Navigation System
    • 5.1.2 Consumable and Accessories
    • 5.1.3 Software and Services
  • 5.2 By Application
    • 5.2.1 Gynecological Surgery
    • 5.2.2 Cardiovascular
    • 5.2.3 Neurosurgery
    • 5.2.4 Orthopedic Surgery
    • 5.2.5 Laparoscopy
    • 5.2.6 Urology
    • 5.2.7 Other Applications
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Ambulatory Surgery Centers
    • 5.3.3 Other End Users
  • 5.4 By Geography
    • 5.4.1 North America
      • United States (by Product Type, Application, and End User)
      • Canada (by Product Type, Application, and End User)
      • Mexico (by Product Type, Application, and End User)
    • 5.4.2 Europe
      • Germany (by Product Type, Application, and End User)
      • United Kingdom (by Product Type, Application, and End User)
      • France (by Product Type, Application, and End User)
      • Italy (by Product Type, Application, and End User)
      • Spain (by Product Type, Application, and End User)
      • Rest of Europe (by Product Type, Application, and End User)
    • 5.4.3 Asia Pacific
      • China (by Product Type, Application, and End User)
      • Japan (by Product Type, Application, and End User)
      • India (by Product Type, Application, and End User)
      • Australia (by Product Type, Application, and End User)
      • South Korea (by Product Type, Application, and End User)
      • Rest of Asia-Pacific (by Product Type, Application, and End User)
    • 5.4.4 Rest of the World


  • 6.1 Company Profiles
    • 6.1.1 Intuitive Surgical Inc.
    • 6.1.2 Stryker Corporation
    • 6.1.3 Johnson & Johnson Inc. (Verb Surgical Inc. and Auris Health Inc.)
    • 6.1.4 SRI International Inc.
    • 6.1.5 Accuray Incorporated
    • 6.1.6 Think Surgical Inc.
    • 6.1.7 Renishaw PLC
    • 6.1.8 Medtronic PLC
    • 6.1.9 Smith & Nephew PLC
    • 6.1.10 Brainlab
    • 6.1.11 NuVasive Inc.
    • 6.1.12 Avatera Medical GmbH
    • 6.1.13 Globus Medical
    • 6.1.14 Zimmer Biomet


Back to Top
전화 문의